Overview

Fecal Microbial Transplant in Pediatric Crohn's Disease

Status:
Terminated
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This is a double blind placebo control trial of fecal microbial transplantation for active Crohn's disease in patients 12 to 21 years of age.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Seattle Children's Hospital
Treatments:
Omeprazole
Polyethylene glycol 3350
Rifaximin